This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (520)  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in JAMA  Topic Collections  • Viral Infections  • Alert me on articles by topic

William W. Thompson, PhD; David K. Shay, MD, MPH; Eric Weintraub, MPH; Lynnette Brammer, MPH; Nancy Cox, PhD; Larry J. Anderson, MD; Keiji Fukuda, MD, MPH

JAMA. 2003;289:179-186.

Context  Influenza and respiratory syncytial virus (RSV) cause substantial morbidity and mortality. Statistical methods used to estimate deaths in the United States attributable to influenza have not accounted for RSV circulation.

Objective  To develop a statistical model using national mortality and viral surveillance data to estimate annual influenza- and RSV-associated deaths in the United States, by age group, virus, and influenza type and subtype.

Design, Setting, and Population  Age-specific Poisson regression models using national viral surveillance data for the 1976-1977 through 1998-1999 seasons were used to estimate influenza-associated deaths. Influenza- and RSV-associated deaths were simultaneously estimated for the 1990-1991 through 1998-1999 seasons.

Main Outcome Measures  Attributable deaths for 3 categories: underlying pneumonia and influenza, underlying respiratory and circulatory, and all causes.

Results  Annual estimates of influenza-associated deaths increased significantly between the 1976-1977 and 1998-1999 seasons for all 3 death categories (P<.001 for each category). For the 1990-1991 through 1998-1999 seasons, the greatest mean numbers of deaths were associated with influenza A(H3N2) viruses, followed by RSV, influenza B, and influenza A(H1N1). Influenza viruses and RSV, respectively, were associated with annual means (SD) of 8097 (3084) and 2707 (196) underlying pneumonia and influenza deaths, 36 155 (11 055) and 11 321 (668) underlying respiratory and circulatory deaths, and 51 203 (15 081) and 17 358 (1086) all-cause deaths. For underlying respiratory and circulatory deaths, 90% of influenza- and 78% of RSV-associated deaths occurred among persons aged 65 years or older. Influenza was associated with more deaths than RSV in all age groups except for children younger than 1 year. On average, influenza was associated with 3 times as many deaths as RSV.

Conclusions  Mortality associated with both influenza and RSV circulation disproportionately affects elderly persons. Influenza deaths have increased substantially in the last 2 decades, in part because of aging of the population, underscoring the need for better prevention measures, including more effective vaccines and vaccination programs for elderly persons.

Author Affiliations: Influenza Branch (Drs Thompson, Cox, and Fukuda, and Mr Weintraub and Ms Brammer) and Respiratory and Enteric Viruses Branch (Drs Shay and Anderson), Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga. Drs Thompson and Shay, and Mr Weintraub are now with the Immunization Safety Branch, Epidemiology and Surveillance Division, National Immunization Program.

RELATED LETTER

Influenza Vaccination Among the Elderly in the United States—Reply
Lone Simonsen, Thomas A. Reichert, Cecile Viboud, William C. Blackwelder, Robert J. Taylor, and Mark A. Miller
Arch Intern Med. 2005;165(17):2039-2040.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Influenza-Related Mortality: Considerations for Practice and Public Health
David M. Morens
JAMA. 2003;289(2):227-229.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Comparative Efficacy of Neutralizing Antibodies Elicited by Recombinant Hemagglutinin Proteins from Avian H5N1 Influenza Virus
Wei et al.
J. Virol. 2008;82:6200-6208.
ABSTRACT | FULL TEXT  

Improving Immunization Rates: Initial Results From a Team-Based, Systems Change Approach
Reynolds et al.
American Journal of Medical Quality 2008;23:176-183.
ABSTRACT  

Interim Within-Season Estimate of the Effectiveness of Trivalent Inactivated Influenza Vaccine--Marshfield, Wisconsin, 2007-08 Influenza Season
JAMA 2008;299:2381-2384.
FULL TEXT  

Homologous Recombination Is Very Rare or Absent in Human Influenza A Virus
Boni et al.
J. Virol. 2008;82:4807-4811.
ABSTRACT | FULL TEXT  

Trends in Recorded Influenza Mortality: United States, 1900-2004
Doshi
Am. J. Public Health 2008;98:939-945.
ABSTRACT | FULL TEXT  

The Fusion Protein of Respiratory Syncytial Virus Triggers p53-Dependent Apoptosis
Eckardt-Michel et al.
J. Virol. 2008;82:3236-3249.
ABSTRACT | FULL TEXT  

Coverages and factors associated with influenza vaccination among subjects with chronic respiratory diseases in Spain
Lopez-de-Andres et al.
Eur J Public Health 2008;18:173-177.
ABSTRACT | FULL TEXT  

Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies
Carrat et al.
Am J Epidemiol 2008;167:775-785.
ABSTRACT | FULL TEXT  

Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2007-2008
Committee on Infectious Diseases
Pediatrics 2008;121:e1016-e1031.
ABSTRACT | FULL TEXT  

Recombinant simian varicella viruses expressing respiratory syncytial virus antigens are immunogenic
Ward et al.
J. Gen. Virol. 2008;89:741-750.
ABSTRACT | FULL TEXT  

Acute respiratory infections and winter pressures on hospital admissions in England and Wales 1990-2005
Elliot et al.
J Public Health (Oxf) 2008;30:91-98.
ABSTRACT | FULL TEXT  

Differential Role of Gamma Interferon in Inhibiting Pulmonary Eosinophilia and Exacerbating Systemic Disease in Fusion Protein-Immunized Mice Undergoing Challenge Infection with Respiratory Syncytial Virus
Castilow et al.
J. Virol. 2008;82:2196-2207.
ABSTRACT | FULL TEXT  

Safety and Immunogenicity of Concurrent Administration of Live Attenuated Influenza Vaccine With Measles-Mumps-Rubella and Varicella Vaccines to Infants 12 to 15 Months of Age
Nolan et al.
Pediatrics 2008;121:508-516.
ABSTRACT | FULL TEXT  

Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus
Pappas et al.
Proc. Natl. Acad. Sci. USA 2008;105:3064-3069.
ABSTRACT | FULL TEXT  

IL-13 Is Required for Eosinophil Entry into the Lung during Respiratory Syncytial Virus Vaccine-Enhanced Disease
Castilow et al.
J. Immunol. 2008;180:2376-2384.
ABSTRACT | FULL TEXT  

Reason for optimism
Doshi
BMJ 2008;336:172-172.
FULL TEXT  

The Influenza Virus Resource at the National Center for Biotechnology Information
Bao et al.
J. Virol. 2008;82:596-601.
FULL TEXT  

Protective effect of low-concentration chlorine dioxide gas against influenza A virus infection
Ogata and Shibata
J. Gen. Virol. 2008;89:60-67.
ABSTRACT | FULL TEXT  

Induction of type I interferons and interferon-inducible Mx genes during respiratory syncytial virus infection and reinfection in cotton rats
Pletneva et al.
J. Gen. Virol. 2008;89:261-270.
ABSTRACT | FULL TEXT  

Effectiveness of Influenza Vaccination
Belongia et al.
NEJM 2007;357:2728-2731.
FULL TEXT  

Influenza- and respiratory syncytial virus-associated mortality and hospitalisations
Jansen et al.
Eur Respir J 2007;30:1158-1166.
ABSTRACT | FULL TEXT  

Historical Comparisons of Morbidity and Mortality for Vaccine-Preventable Diseases in the United States
Roush et al.
JAMA 2007;298:2155-2163.
ABSTRACT | FULL TEXT  

Rectification of Age-Associated Deficiency in Cytotoxic T Cell Response to Influenza A Virus by Immunization with Immune Complexes
Zheng et al.
J. Immunol. 2007;179:6153-6159.
ABSTRACT | FULL TEXT  

Effectiveness of Influenza Vaccine in the Community-Dwelling Elderly
Nichol et al.
NEJM 2007;357:1373-1381.
ABSTRACT | FULL TEXT  

Influenza Vaccination: An Unmet Need in Patients With Diabetes
Schaffner et al.
Clin. Diabetes 2007;25:145-149.
ABSTRACT | FULL TEXT  

Viral Tropism and the Pathogenesis of Influenza in the Mammalian Host
Mansfield
Am. J. Pathol. 2007;171:1089-1092.
FULL TEXT  

RSV604, a Novel Inhibitor of Respiratory Syncytial Virus Replication
Chapman et al.
Antimicrob. Agents Chemother. 2007;51:3346-3353.
ABSTRACT | FULL TEXT  

Respiratory Syncytial Virus Infects and Abortively Replicates in the Lungs in Spite of Preexisting Immunity
Boukhvalova et al.
J. Virol. 2007;81:9443-9450.
ABSTRACT | FULL TEXT  

Viral Etiology of Acute Exacerbations of COPD in Hong Kong
Ko et al.
Chest 2007;132:900-908.
ABSTRACT | FULL TEXT  

Thymosin Alpha 1 as an Adjunct to Influenza Vaccination in the Elderly: Rationale and Trial Summaries
ERSHLER et al.
Ann. N. Y. Acad. Sci. 2007;1112:375-384.
ABSTRACT | FULL TEXT  

Association of TLR4 Polymorphisms with Symptomatic Respiratory Syncytial Virus Infection in High-Risk Infants and Young Children
Awomoyi et al.
J. Immunol. 2007;179:3171-3177.
ABSTRACT | FULL TEXT  

Trivalent Live Attenuated Intranasal Influenza Vaccine Administered During the 2003 2004 Influenza Type A (H3N2) Outbreak Provided Immediate, Direct, and Indirect Protection in Children
Piedra et al.
Pediatrics 2007;120:e553-e564.
ABSTRACT | FULL TEXT  

FluGenome: a web tool for genotyping influenza A virus
Lu et al.
Nucleic Acids Res 2007;35:W275-W279.
ABSTRACT | FULL TEXT  

Mass Distribution of Free, Intranasally Administered Influenza Vaccine in a Public School System
Carpenter et al.
Pediatrics 2007;120:e172-e178.
ABSTRACT | FULL TEXT  

Commentary: Observational studies and the art of accurately measuring influenza vaccine benefits
Simonsen
Int J Epidemiol 2007;0:dym084v1-2.
FULL TEXT  

The Relationship Between Early Respiratory Viral Infections and Subsequent Wheezing and Asthma
Panitch
CLIN PEDIATR 2007;46:392-400.
 

The Next Influenza Pandemic: Can It Be Predicted?
Taubenberger et al.
JAMA 2007;297:2025-2027.
FULL TEXT  

Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34 892 subjects
Madjid et al.
Eur Heart J 2007;28:1205-1210.
ABSTRACT | FULL TEXT  

MyD88-Mediated Instructive Signals in Dendritic Cells Regulate Pulmonary Immune Responses during Respiratory Virus Infection
Rudd et al.
J. Immunol. 2007;178:5820-5827.
ABSTRACT | FULL TEXT  

Vaccine Effectiveness Against Medically Attended, Laboratory-Confirmed Influenza Among Children Aged 6 to 59 Months, 2003-2004
Shuler et al.
Pediatrics 2007;119:e587-e595.
ABSTRACT | FULL TEXT  

Retinoic Acid-Inducible Gene I Mediates Early Antiviral Response and Toll-Like Receptor 3 Expression in Respiratory Syncytial Virus-Infected Airway Epithelial Cells
Liu et al.
J. Virol. 2007;81:1401-1411.
ABSTRACT | FULL TEXT  

Brief Report: Respiratory Syncytial Virus Activity--United States, 2005-2006
JAMA 2007;297:356-357.
FULL TEXT  

Influenza Vaccination and Risk of Mortality Among Adults Hospitalized With Community-Acquired Pneumonia
Spaude et al.
Arch Intern Med 2007;167:53-59.
ABSTRACT | FULL TEXT  

Comparison of the Influenza Virus-Specific Effector and Memory B-Cell Responses to Immunization of Children and Adults with Live Attenuated or Inactivated Influenza Virus Vaccines
Sasaki et al.
J. Virol. 2007;81:215-228.
ABSTRACT | FULL TEXT  

Epochal Evolution Shapes the Phylodynamics of Interpandemic Influenza A (H3N2) in Humans
Koelle et al.
Science 2006;314:1898-1903.
ABSTRACT | FULL TEXT  

Inhibition of Influenza Virus Infection by a Novel Antiviral Peptide That Targets Viral Attachment to Cells
Jones et al.
J. Virol. 2006;80:11960-11967.
ABSTRACT | FULL TEXT  

Epidemiology, Complications, and Cost of Hospitalization in Children With Laboratory-Confirmed Influenza Infection
Ampofo et al.
Pediatrics 2006;118:2409-2417.
ABSTRACT | FULL TEXT  

Direct Medical Cost of Influenza-Related Hospitalizations in Children
Keren et al.
Pediatrics 2006;118:e1321-e1327.
ABSTRACT | FULL TEXT  

Influenza Vaccination as Secondary Prevention for Cardiovascular Disease: A Science Advisory From the American Heart Association/American College of Cardiology
Davis et al.
J Am Coll Cardiol 2006;48:1498-1502.
ABSTRACT | FULL TEXT  

Influenza Vaccination as Secondary Prevention for Cardiovascular Disease: A Science Advisory From the American Heart Association/American College of Cardiology: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Association of Critical Care Nurses, the American Association of Heart Failure Nurses, the American Diabetes Association, the Association of Black Cardiologists, Inc., the Heart Failure Society of America, and the Preventive Cardiovascular Nurses Association.: The American Academy of Nurse Practitioners supports the recommendations of this scientific advisory.: This science advisory is consistent with the recommendations of the Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices.
Davis et al.
Circulation 2006;114:1549-1553.
ABSTRACT | FULL TEXT  

Emerging Respiratory Viruses: Challenges and Vaccine Strategies
Gillim-Ross and Subbarao
Clin. Microbiol. Rev. 2006;19:614-636.
ABSTRACT | FULL TEXT  

Influenza Vaccination Coverage of Children Aged 6 to 23 Months: The 2002-2003 and 2003-2004 Influenza Seasons
Santibanez et al.
Pediatrics 2006;118:1167-1175.
ABSTRACT | FULL TEXT  

Kinetics of influenza a virus infection in humans.
Baccam et al.
J. Virol. 2006;80:7590-7599.
ABSTRACT | FULL TEXT  

Distribution of Influenza Vaccine to High-Risk Groups
Ompad et al.
Epidemiol Rev 2006;28:54-70.
ABSTRACT | FULL TEXT  

Delivering Influenza Vaccine to Pregnant Women
Naleway et al.
Epidemiol Rev 2006;28:47-53.
ABSTRACT | FULL TEXT  

Interdisciplinary Epidemiologic and Economic Research Needed to Support a Universal Childhood Influenza Vaccination Policy
Coleman et al.
Epidemiol Rev 2006;28:41-46.
ABSTRACT | FULL TEXT  

Insights into the Interaction between Influenza Virus and Pneumococcus
McCullers
Clin. Microbiol. Rev. 2006;19:571-582.
ABSTRACT | FULL TEXT  

Influenza and Other Respiratory Virus-Related Emergency Department Visits Among Young Children
Bourgeois et al.
Pediatrics 2006;118:e1-e8.
ABSTRACT | FULL TEXT  

Bias in studies of influenza vaccine effectiveness: the authors reply to Hak et al.
JACKSON et al.
Int J Epidemiol 2006;35:799-800.
FULL TEXT  

T Cell Responses Are Better Correlates of Vaccine Protection in the Elderly
McElhaney et al.
J. Immunol. 2006;176:6333-6339.
ABSTRACT | FULL TEXT  

Bacterial Sinusitis and Otitis Media following Influenza Virus Infection in Ferrets.
Peltola et al.
Infect. Immun. 2006;74:2562-2567.
ABSTRACT | FULL TEXT  

Bridging Disparity: A Multidisciplinary Approach for Influenza Vaccination in an American Indian Community
Traeger et al.
Am. J. Public Health 2006;96:921-925.
ABSTRACT | FULL TEXT  

Broad-spectrum respiratory tract pathogen identification using resequencing DNA microarrays
Lin et al.
Genome Res. 2006;16:527-535.
ABSTRACT | FULL TEXT  

Commentary: Benefits of influenza vaccine in US elderly--new studies raise questions
Glezen and Simonsen
Int J Epidemiol 2006;35:352-353.
FULL TEXT  

Severe Pediatric Influenza in California, 2003-2005: Implications for Immunization Recommendations
Louie et al.
Pediatrics 2006;117:e610-e618.
ABSTRACT | FULL TEXT  

Racial and Ethnic Disparities in Influenza Vaccination Coverage among Adults during the 2004-2005 Season
Link et al.
Am J Epidemiol 2006;163:571-578.
ABSTRACT | FULL TEXT  

COPD exacerbations {middle dot} 2: Aetiology.
Sapey and Stockley
Thorax 2006;61:250-258.
ABSTRACT | FULL TEXT  

High Levels of Adamantane Resistance Among Influenza A (H3N2) Viruses and Interim Guidelines for Use of Antiviral Agents--United States, 2005-06 Influenza Season
JAMA 2006;295:881-882.
FULL TEXT  

Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States
Bright et al.
JAMA 2006;295:891-894.
ABSTRACT | FULL TEXT  

Patterns of Influenza-associated Mortality among US Elderly by Geographic Region and Virus Subtype, 1968-1998
Greene et al.
Am J Epidemiol 2006;163:316-326.
ABSTRACT | FULL TEXT  

Efficacy of Quinolones against Secondary Pneumococcal Pneumonia after Influenza Virus Infection in Mice
Hayashi et al.
Antimicrob. Agents Chemother. 2006;50:748-751.
ABSTRACT | FULL TEXT  

The cytoplasmic domain of the F protein of Human respiratory syncytial virus is not required for cell fusion
Branigan et al.
J. Gen. Virol. 2006;87:395-398.
ABSTRACT | FULL TEXT  

Influenza Among Healthy Young Children: Changes in Parental Attitudes and Predictors of Immunization During the 2003 to 2004 Influenza Season
Daley et al.
Pediatrics 2006;117:e268-e277.
ABSTRACT | FULL TEXT  

US flu mortality estimates are based on solid science
Simonsen et al.
BMJ 2006;332:177-178.
FULL TEXT  

Brief Report: Respiratory Syncytial Virus Activity--United States, 2004-2005
JAMA 2006;295:267-268.
FULL TEXT  

Mortality due to Influenza in the United States--An Annualized Regression Approach Using Multiple-Cause Mortality Data
Dushoff et al.
Am J Epidemiol 2006;163:181-187.
ABSTRACT | FULL TEXT  

Preschoolers' Respiratory Illness Predicts Influenza Mortality in All Age Groups
Aldous
AAP Grand Rounds 2006;15:6-7.
FULL TEXT  

Influenza -- Interpandemic as Well as Pandemic Disease
Dolin
NEJM 2005;353:2535-2537.
FULL TEXT  

Influenza-Associated Deaths among Children in the United States, 2003-2004
Bhat et al.
NEJM 2005;353:2559-2567.
ABSTRACT | FULL TEXT  

Are US flu death figures more PR than science?
Doshi
BMJ 2005;331:1412-1412.
FULL TEXT  

Trends in Hospitalizations for Pneumonia Among Persons Aged 65 Years or Older in the United States, 1988-2002
Fry et al.
JAMA 2005;294:2712-2719.
ABSTRACT | FULL TEXT  

Contrasting Effects of Cyclooxygenase-1 (COX-1) and COX-2 Deficiency on the Host Response to Influenza A Viral Infection
Carey et al.
J. Immunol. 2005;175:6878-6884.
ABSTRACT | FULL TEXT  

An improved reverse genetics system for influenza A virus generation and its implications for vaccine production
Neumann et al.
Proc. Natl. Acad. Sci. USA 2005;102:16825-16829.
ABSTRACT | FULL TEXT  

Influenza Vaccine Confusion: A Call for an Alternative Evidence-Based Approach
Yogev
Pediatrics 2005;116:1214-1215.
FULL TEXT  

Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins
Falcon et al.
J. Gen. Virol. 2005;86:2817-2821.
ABSTRACT | FULL TEXT  

BIOTERRORISM PREPAREDNESS EXPENDITURES MAY COMPROMISE PUBLIC HEALTH
Dowling and Lipton
Am. J. Public Health 2005;95:1672-1672.
FULL TEXT  

Missed Opportunities for Influenza Vaccination in Children With Chronic Medical Conditions
Daley et al.
Arch Pediatr Adolesc Med 2005;159:986-991.
ABSTRACT | FULL TEXT  

Identifying Pediatric Age Groups for Influenza Vaccination Using a Real-Time Regional Surveillance System
Brownstein et al.
Am J Epidemiol 2005;162:686-693.
ABSTRACT | FULL TEXT